Navigation Links
Roche Diabetes Care Forms Human Blue Circle, Supports Viral Video for World Diabetes Day
Date:11/11/2010

INDIANAPOLIS, Nov. 11, 2010 /PRNewswire/ -- Roche Diabetes Care, makers of ACCU-CHEK® products and services, is showing its support for World Diabetes Day (Nov. 14) through two truly collaborative initiatives.

(Photo: http://photos.prnewswire.com/prnh/20101111/DE99363)

(Photo: http://www.newscom.com/cgi-bin/prnh/20101111/DE99363)

Roche Diabetes Care formed its first human blue circle this year as a demonstration of support for people around the world with diabetes. The blue circle is the official logo of World Diabetes Day and is often duplicated in "human form" as a demonstrable act of support for WDD's effort to increase diabetes advocacy and awareness. Nearly 200 Roche employees formed the blue circle, which can be viewed on the ACCU-CHEK World Diabetes Day page.*

Roche Diabetes Care is also proud to have partnered with the Diabetes Hands Foundation, Diabetes Daily and Diabetes Stories to sponsor a video for the Big Blue Test. The video, located at http://www.youtube.com/watch?v=nkLHgK94Z0E, encourages people with diabetes to test their blood sugar on Nov. 14, get active for 14 minutes and then test again. The Big Blue Test, now in its second year, helps people with diabetes better understand the positive impact they can have on their blood sugar. Roche Diabetes Care underwrote the cost of the video's production and will make a donation for every view the video receives up to $75,000.

"The two initiatives underscore Roche's commitment to advocacy, awareness and education when it comes to diabetes," said Luc Vierstraete, senior vice president and general manager, Roche Diabetes Care North America. "We're thankful to have such wonderful partners in the diabetes community and hope that our Human Blue Circle and Big Blue Test video encourage others to get involved and make a difference in their communities."

World Diabetes Day is celebrated every year on Nov. 14 and was created by the International Diabetes Foundation and the World Health Organization. Since 2007 it has been recognized as an official United Nations Day.

* Publications may use the high-quality image attached to this release or e-mail todd.siesky@roche.com for an publish-ready image.

About Roche Diabetes CareRoche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management—from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems. For more information, please visit accu-chek.com.

About RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com or www.roche-diagnostics.us.

All trademarks used or mentioned in this release are protected by law.For further information, please contact: Todd Siesky Public Relations ManagerRoche Diabetes CareIndianapolis, IN(317) 521-3966 O(317) 361-7637 Ctodd.siesky@roche.com
'/>"/>

SOURCE Roche Diabetes Care
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
2. InterMune Sells Danoprevir Rights to Roche for $175 Million
3. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
4. Sanford Rose Associates(R)-Rochester Named Top Office
5. Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
6. Roche Diabetes Care and ICW Announce Technology Partnership
7. International Society for Cellular Therapy (ISCT) joins forces with Roche and Genzyme to launch Cell Therapy Industry Partnership.
8. X-Chem and Roche Enter Into Drug Discovery Collaboration and License Agreement
9. QIAGEN and Roche Settle Dispute Over Distribution Agreement for TheraScreen Companion Diagnostics
10. Cellular Dynamics and Roche Conduct Stem Cells in Drug Discovery and Development Workshop at the Society of Toxicology Annual Meeting
11. EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
Breaking Biology Technology:
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):